- Home
- BTAI vs GYRO Comparison
BTAI vs GYRO Comparison
Compare BTAI & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- GYRO
- Stock Information
- Founded
- BTAI 2017
- GYRO 1946
- Country
- BTAI United States
- GYRO United States
- Employees
- BTAI N/A
- GYRO N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- GYRO Building operators
- Sector
- BTAI Health Care
- GYRO Real Estate
- Exchange
- BTAI Nasdaq
- GYRO Nasdaq
- Market Cap
- BTAI 18.1M
- GYRO 19.8M
- IPO Year
- BTAI 2018
- GYRO N/A
- Fundamental
- Price
- BTAI $0.34
- GYRO $9.22
- Analyst Decision
- BTAI Buy
- GYRO
- Analyst Count
- BTAI 4
- GYRO 0
- Target Price
- BTAI $2.81
- GYRO N/A
- AVG Volume (30 Days)
- BTAI 1.3M
- GYRO 467.0
- Earning Date
- BTAI 03-11-2025
- GYRO 01-01-0001
- Dividend Yield
- BTAI N/A
- GYRO N/A
- EPS Growth
- BTAI N/A
- GYRO N/A
- EPS
- BTAI N/A
- GYRO N/A
- Revenue
- BTAI $2,276,000.00
- GYRO $2,738,019.00
- Revenue This Year
- BTAI $131.23
- GYRO N/A
- Revenue Next Year
- BTAI $45.79
- GYRO N/A
- P/E Ratio
- BTAI N/A
- GYRO N/A
- Revenue Growth
- BTAI 83.25
- GYRO N/A
- 52 Week Low
- BTAI $0.30
- GYRO $7.65
- 52 Week High
- BTAI $4.17
- GYRO $11.96
- Technical
- Relative Strength Index (RSI)
- BTAI 42.14
- GYRO 49.42
- Support Level
- BTAI $0.33
- GYRO $9.02
- Resistance Level
- BTAI $0.39
- GYRO $9.88
- Average True Range (ATR)
- BTAI 0.06
- GYRO 0.01
- MACD
- BTAI -0.00
- GYRO 0.01
- Stochastic Oscillator
- BTAI 9.27
- GYRO 52.63
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About GYRO Gyrodyne LLC
Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.